Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 119520-06-8
2. Zilpaterol Hcl
3. Ex8iep25ju
4. (9r,10r)-9-hydroxy-10-(propan-2-ylamino)-1,3-diazatricyclo[6.4.1.04,13]trideca-4,6,8(13)-trien-2-one;hydrochloride
5. 9-hydroxy-10-(propan-2-ylamino)-1,3-diazatricyclo[6.4.1.04,13]trideca-4,6,8(13)-trien-2-one;hydrochloride
6. Imidazo(4,5,1-jk)(1)benzazepin-2(1h)-one, 4,5,6,7-tetrahydro-7-hydroxy-6-((1-methylethyl)amino)-, Monohydrochloride
7. Rac-(6r,7r)-7-hydroxy-6-(isopropylamino)-4,5,6,7-tetrahydroimidazo(4,5,1-jk)(1)benzazepin-2(1h)-one Hydrochloride
8. Unii-ex8iep25ju
9. Schembl135498
10. Chembl513390
11. Amy23433
12. Mfcd09033213
13. Zilpaterol Hydrochloride [mi]
14. Akos015967220
15. Zilpaterol Hydrochloride [mart.]
16. Zilpaterol Hydrochloride [green Book]
17. 520z068
18. A903870
19. J-501696
20. Q27277408
21. (6r,7r)-6-hydroxy-7-(isopropylamino)-6,7,8,9-tetrahydro-2,9a-diazabenzo[cd]azulen-1(2h)-one Hydrochloride
22. (9r,10r)-9-hydroxy-10-[(propan-2-yl)amino]-1,3-diazatricyclo[6.4.1.0?,??]trideca-4,6,8(13)-trien-2-one Hydrochloride
23. Trans-4,5,6,7-tetrahydro-7-hydroxy-6-(isopropylamino)imidazo[4,5,1-jk]-[1]benzazepin-2(1h)-one Hydrochloride
Molecular Weight | 297.78 g/mol |
---|---|
Molecular Formula | C14H20ClN3O2 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 297.1244046 g/mol |
Monoisotopic Mass | 297.1244046 g/mol |
Topological Polar Surface Area | 64.6 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 361 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Zilpaterol hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zilpaterol hydrochloride, including repackagers and relabelers. The FDA regulates Zilpaterol hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zilpaterol hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zilpaterol hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zilpaterol hydrochloride supplier is an individual or a company that provides Zilpaterol hydrochloride active pharmaceutical ingredient (API) or Zilpaterol hydrochloride finished formulations upon request. The Zilpaterol hydrochloride suppliers may include Zilpaterol hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Zilpaterol hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zilpaterol hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zilpaterol hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zilpaterol hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zilpaterol hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zilpaterol hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zilpaterol hydrochloride suppliers with NDC on PharmaCompass.
Zilpaterol hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zilpaterol hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zilpaterol hydrochloride GMP manufacturer or Zilpaterol hydrochloride GMP API supplier for your needs.
A Zilpaterol hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Zilpaterol hydrochloride's compliance with Zilpaterol hydrochloride specifications and serves as a tool for batch-level quality control.
Zilpaterol hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Zilpaterol hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zilpaterol hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Zilpaterol hydrochloride EP), Zilpaterol hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zilpaterol hydrochloride USP).
LOOKING FOR A SUPPLIER?